Evaluation of S100B Serum Level as a Biomarker of Disease Activity in Vitiligo Patients

International Journal of Medical Arts
doi 10.21608/ijma.2019.12021.1001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Egypts Presidential Specialized Council for Education and Scientific Research

Related search

Serum Levels of S100B From Jugular Bulb as a Biomarker of Poor Prognosis in Patients With Severe Acute Brain Injury

Journal of the Neurological Sciences
Neurology
2018English

449 CXCL9 as a Biomarker for Disease Activity in Patients With Morphea

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Serum Osteoprotegerin as a Biomarker for Vascular Disease

American Journal of Cardiology
Cardiovascular MedicineCardiology
2007English

Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease

PLoS ONE
Multidisciplinary
2015English

S100B as a Biomarker for Brain Metastases in Patients With Non‑small Cell Lung Cancer

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2020English

High Level of Tumor Necrosis Alpha and Serum Interferon Gamma as Risk Factors for Progression of Vitiligo Disease

International Journal of Health Sciences (IJHS)
2018English

Evaluation of Serum Neurokinin a Level in Alopecia Areata Patients

Benha Medical Journal
2020English

Potentialities of Evaluation of Serum Level of S100B for Predicting the Consequences of Severe Traumatic Brain Injury

Ukrainian Neurosurgical Journal
2017English

Serum-Prolactin Levels in Patients With Vitiligo

Journal of Clinical and Analytical Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy